Status and phase
Conditions
Treatments
About
This is a clinical study to evaluate the safety, tolerability and initial efficacy of SKG0106 intravitreal injection in diabetic macular edema (DME) patients.
Full description
This is an open, dose-escalation clinical study to evaluate the safety, tolerability and initial efficacy of SKG0106 intravitreal injection in diabetic macular edema (DME) patients in China.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Written informed consent must be obtained prior to all assessments.
Age ≥18 years at screening.
Type 1 or type 2 diabetes mellitus at screening.
Study eye criteria:
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
18 participants in 1 patient group
Loading...
Central trial contact
Min Wang, Doctor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal